In multiple myeloma and diffuse large B cell lymphoma, where high expression of MYC is a consequence of an active super-enhancer element proximal to MYC gene, BET inhibition induces strong MYC downregulation [18,36]. Here, MYC is linked to diffuse large B-cell lymphoma.